News
U.S. aid cuts could jeopardize the supply of donated drugs that are hailed for their effectiveness in combating neglected ...
Procter & Gamble said Thursday it plans to cut 7,000 jobs, about 15% of its workforce, over two years. The company said it's ...
Alvotech (NASDAQ:ALVO) and Dr. Reddy’s Laboratories (NYSE:RDY) have entered into a collaboration and license agreement to ...
An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.
The guideline recommendations advise universal use of hydroxychloroquine, minimizing steroids, and earlier introduction of ...
21h
MedPage Today on MSNWin for Added Relacorilant in Platinum-Resistant Ovarian CancerIn addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...
This was the stock's second consecutive day of gains.
Dr. Reddy's Laboratories and Alvotech have partnered to co-develop, manufacture, and commercialize a biosimilar of Keytruda ...
Dr. Reddy's Laboratories and Alvotech are collaborating to develop, manufacture, and commercialize a biosimilar version of ...
Merck secures U.S. Patent Office backing in its legal battle with Halozyme over Keytruda's injectable version. Read more here ...
1h
Zacks Investment Research on MSNRDY & ALVO Ink Collaboration Deal for Merck's Keytruda BiosimilarDr. Reddy’s Laboratories RDY announced that it has entered into a collaboration and license agreement with Alvotech ALVO to ...
The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results